Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

NMDA-receptor inhibition and oxidative stress during hippocampal maturation differentially alter parvalbumin expression and gamma-band activity.

Hasam-Henderson LA, Gotti GC, Mishto M, Klisch C, Gerevich Z, Geiger JRP, Kovács R.

Sci Rep. 2018 Jun 22;8(1):9545. doi: 10.1038/s41598-018-27830-2.

2.

Contribution of Intrinsic Lactate to Maintenance of Seizure Activity in Neocortical Slices from Patients with Temporal Lobe Epilepsy and in Rat Entorhinal Cortex.

Angamo EA, ul Haq R, Rösner J, Gabriel S, Gerevich Z, Heinemann U, Kovács R.

Int J Mol Sci. 2017 Aug 23;18(9). pii: E1835. doi: 10.3390/ijms18091835.

3.

Aberrant alpha and gamma oscillations ex vivo after single application of the NMDA receptor antagonist MK-801.

Lemercier CE, Holman C, Gerevich Z.

Schizophr Res. 2017 Oct;188:118-124. doi: 10.1016/j.schres.2017.01.017. Epub 2017 Jan 18.

PMID:
28109667
4.

Adenosine A1 receptor-mediated suppression of carbamazepine-resistant seizure-like events in human neocortical slices.

Klaft ZJ, Hollnagel JO, Salar S, Calişkan G, Schulz SB, Schneider UC, Horn P, Koch A, Holtkamp M, Gabriel S, Gerevich Z, Heinemann U.

Epilepsia. 2016 May;57(5):746-56. doi: 10.1111/epi.13360. Epub 2016 Apr 18.

5.

P2Y Receptors in Synaptic Transmission and Plasticity: Therapeutic Potential in Cognitive Dysfunction.

Guzman SJ, Gerevich Z.

Neural Plast. 2016;2016:1207393. doi: 10.1155/2016/1207393. Epub 2016 Mar 16. Review.

6.

Dopamine D3 Receptors Inhibit Hippocampal Gamma Oscillations by Disturbing CA3 Pyramidal Cell Firing Synchrony.

Lemercier CE, Schulz SB, Heidmann KE, Kovács R, Gerevich Z.

Front Pharmacol. 2016 Jan 6;6:297. doi: 10.3389/fphar.2015.00297. eCollection 2015.

7.

Corticosterone and corticotropin-releasing factor acutely facilitate gamma oscillations in the hippocampus in vitro.

Çalışkan G, Schulz SB, Gruber D, Behr J, Heinemann U, Gerevich Z.

Eur J Neurosci. 2015 Jan;41(1):31-44. doi: 10.1111/ejn.12750. Epub 2014 Oct 13.

PMID:
25306895
8.

Extracellular ATP differentially affects epileptiform activity via purinergic P2X7 and adenosine A1 receptors in naive and chronic epileptic rats.

Klaft ZJ, Schulz SB, Maslarova A, Gabriel S, Heinemann U, Gerevich Z.

Epilepsia. 2012 Nov;53(11):1978-86. doi: 10.1111/j.1528-1167.2012.03724.x. Epub 2012 Oct 25.

9.

First and second generation antipsychotics influence hippocampal gamma oscillations by interactions with 5-HT3 and D3 receptors.

Schulz SB, Heidmann KE, Mike A, Klaft ZJ, Heinemann U, Gerevich Z.

Br J Pharmacol. 2012 Dec;167(7):1480-91. doi: 10.1111/j.1476-5381.2012.02107.x.

10.

Purinergic P2X, P2Y and adenosine receptors differentially modulate hippocampal gamma oscillations.

Schulz SB, Klaft ZJ, Rösler AR, Heinemann U, Gerevich Z.

Neuropharmacology. 2012 Feb;62(2):914-24. doi: 10.1016/j.neuropharm.2011.09.024. Epub 2011 Oct 8.

PMID:
22001427
11.

P2Y1 receptors inhibit long-term depression in the prefrontal cortex.

Guzman SJ, Schmidt H, Franke H, Krügel U, Eilers J, Illes P, Gerevich Z.

Neuropharmacology. 2010 Nov;59(6):406-15. doi: 10.1016/j.neuropharm.2010.05.013. Epub 2010 Jun 4.

PMID:
20570683
12.

Cross-inhibition between native and recombinant TRPV1 and P2X(3) receptors.

Stanchev D, Blosa M, Milius D, Gerevich Z, Rubini P, Schmalzing G, Eschrich K, Schaefer M, Wirkner K, Illes P.

Pain. 2009 May;143(1-2):26-36. doi: 10.1016/j.pain.2009.01.006. Epub 2009 Feb 14.

PMID:
19223122
13.

[Purinergic modulation of the brain dopaminergic transmission: behavioral-pharmacologic conclusions].

Köles L, Gerevich Z, Kittner H, Krügel U, Franke H, Illés P.

Neuropsychopharmacol Hung. 2008 May;10(2):97-102. Review. Hungarian.

14.

P2Y receptors and pain transmission.

Gerevich Z, Illes P.

Purinergic Signal. 2004 Dec;1(1):3-10. doi: 10.1007/s11302-004-4740-9.

15.

Interaction of P2 purinergic receptors with cellular macromolecules.

Köles L, Gerevich Z, Oliveira JF, Zadori ZS, Wirkner K, Illes P.

Naunyn Schmiedebergs Arch Pharmacol. 2008 Mar;377(1):1-33. doi: 10.1007/s00210-007-0222-2. Epub 2007 Dec 19. Review.

PMID:
18273661
16.

The unusual state-dependent affinity of P2X3 receptors can be explained by an allosteric two-open-state model.

Karoly R, Mike A, Illes P, Gerevich Z.

Mol Pharmacol. 2008 Jan;73(1):224-34. Epub 2007 Oct 9.

17.

Dual effect of acid pH on purinergic P2X3 receptors depends on the histidine 206 residue.

Gerevich Z, Zadori ZS, Köles L, Kopp L, Milius D, Wirkner K, Gyires K, Illes P.

J Biol Chem. 2007 Nov 23;282(47):33949-57. Epub 2007 Sep 21.

18.

Direct inhibitory effect of fluoxetine on N-methyl-D-aspartate receptors in the central nervous system.

Szasz BK, Mike A, Karoly R, Gerevich Z, Illes P, Vizi ES, Kiss JP.

Biol Psychiatry. 2007 Dec 1;62(11):1303-9. Epub 2007 Jul 20.

PMID:
17659262
19.

Metabotropic P2Y receptors inhibit P2X3 receptor-channels via G protein-dependent facilitation of their desensitization.

Gerevich Z, Zadori Z, Müller C, Wirkner K, Schröder W, Rubini P, Illes P.

Br J Pharmacol. 2007 May;151(2):226-36. Epub 2007 Mar 12.

20.

Regulation of intracellular Ca2+ by P2Y1 receptors may depend on the developmental stage of cultured rat striatal neurons.

Rubini P, Pinkwart C, Franke H, Gerevich Z, Nörenberg W, Illes P.

J Cell Physiol. 2006 Oct;209(1):81-93.

PMID:
16783821
21.
22.

Decrease of current responses at human recombinant P2X3 receptors after substitution by Asp of Ser/Thr residues in protein kinase C phosphorylation sites of their ecto-domains.

Stanchev D, Flehmig G, Gerevich Z, Nörenberg W, Dihazi H, Fürst S, Eschrich K, Illes P, Wirkner K.

Neurosci Lett. 2006 Jan 23;393(1):78-83. Epub 2005 Oct 13.

PMID:
16226373
23.

Metabotropic P2Y1 receptors inhibit P2X3 receptor-channels in rat dorsal root ganglion neurons.

Gerevich Z, Müller C, Illes P.

Eur J Pharmacol. 2005 Oct 3;521(1-3):34-8. Epub 2005 Sep 19.

PMID:
16181623
24.

P2Y1 receptors inhibit both strength and plasticity of glutamatergic synaptic neurotransmission in the rat prefrontal cortex.

Guzman SJ, Gerevich Z, Hengstler JG, Illes P, Kleemann W.

Synapse. 2005 Sep 15;57(4):235-8. No abstract available.

PMID:
15986393
25.

Adenosine A2A receptor-induced inhibition of NMDA and GABAA receptor-mediated synaptic currents in a subpopulation of rat striatal neurons.

Wirkner K, Gerevich Z, Krause T, Günther A, Köles L, Schneider D, Nörenberg W, Illes P.

Neuropharmacology. 2004 Jun;46(7):994-1007.

PMID:
15081796
26.

Inhibition of N-type voltage-activated calcium channels in rat dorsal root ganglion neurons by P2Y receptors is a possible mechanism of ADP-induced analgesia.

Gerevich Z, Borvendeg SJ, Schröder W, Franke H, Wirkner K, Nörenberg W, Fürst S, Gillen C, Illes P.

J Neurosci. 2004 Jan 28;24(4):797-807.

27.

Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type.

Wirkner K, Schweigel J, Gerevich Z, Franke H, Allgaier C, Barsoumian EL, Draheim H, Illes P.

Br J Pharmacol. 2004 Jan;141(1):141-51. Epub 2003 Dec 8.

28.

P2Y receptor-mediated inhibition of voltage-dependent Ca2+ channels in rat dorsal root ganglion neurons.

Borvendeg SJ, Gerevich Z, Gillen C, Illes P.

Synapse. 2003 Feb;47(2):159-61. No abstract available.

PMID:
12454954
29.
30.
31.

Analysis of high intracellular [Na+]-induced release of [3H]noradrenaline in rat hippocampal slices.

Gerevich Z, Tretter L, Adam-Vizi V, Baranyi M, Kiss JP, Zelles T, Vizi ES.

Neuroscience. 2001;104(3):761-8.

PMID:
11440807
32.

Excessive release of [3H] noradrenaline by veratridine and ischemia in spinal cord.

Sumiya Y, Torigoe K, Gerevich Z, Köfalvi A, Vizi ES.

Neurochem Int. 2001 Jul;39(1):59-63.

PMID:
11311450
33.

Low temperature prevents potentiation of norepinephrine release by phenylephrine.

Santha E, Lendvai B, Gerevich Z.

Neurochem Int. 2001 Mar;38(3):237-42.

PMID:
11099782
34.

Inhibition by adenosine A(2A) receptors of NMDA but not AMPA currents in rat neostriatal neurons.

Wirkner K, Assmann H, Köles L, Gerevich Z, Franke H, Nörenberg W, Boehm R, Illes P.

Br J Pharmacol. 2000 May;130(2):259-69.

35.

Supplemental Content

Loading ...
Support Center